{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:41:11Z","timestamp":1793850071971,"version":"4.6.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacc.2025.11.027","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T15:32:29Z","timestamp":1765985549000},"page":"891-906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Management of Peripheral Artery Disease in Adults With Diabetes: 2025 ACC Scientific Statement"],"prefix":"10.1016","volume":"88","author":[{"given":"Sandeep R.","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc P.","family":"Bonaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Creager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisa","family":"Maruthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Nordanstig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodica","family":"Pop-Busui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ujueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.11.027_bib1","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.jacc.2024.02.013","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"83","author":"Gornik","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.027_bib2","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.2337\/dc25-S011","article-title":"Chronic kidney disease and risk management: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.11.027_bib3","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0140-6736(25)00509-4","article-title":"Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial","volume":"405","author":"Bonaca","year":"2025","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jacc.2025.11.027_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.027_bib5","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIRCULATIONAHA.120.046524","article-title":"Peripheral artery disease and venous thromboembolic events after acute coronary syndrome: role of lipoprotein(a) and modification by alirocumab: prespecified analysis of the ODYSSEY OUTCOMES randomized clinical trial","volume":"141","author":"Schwartz","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.027_bib6","author":"Jones","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.027_bib7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ejvs.2023.03.042","article-title":"Editor\u2019s Choice: European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on antithrombotic therapy for vascular diseases","volume":"65","author":"Twine","year":"2023","journal-title":"Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg"},{"key":"10.1016\/j.jacc.2025.11.027_bib8","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc25-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.11.027_bib9","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.2337\/dc25-S012","article-title":"12. Retinopathy, neuropathy, and foot care: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.11.027_bib10","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease","volume":"74","author":"Arnett","year":"2019","journal-title":"JACC"},{"key":"10.1016\/j.jacc.2025.11.027_bib11","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa2308743","article-title":"Teplizumab and \u03b2-cell function in newly diagnosed type 1 diabetes","volume":"389","author":"Ramos","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2013.08.003","article-title":"The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI)","volume":"59","author":"Mills","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.11.027_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2025.104226","article-title":"Global, regional, and national burden of peripheral artery disease: a systematic analysis of prevalence, incidence, deaths, and DALYs with projections for the next 15 years","volume":"35","author":"Kou","year":"2025","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"key":"10.1016\/j.jacc.2025.11.027_bib14","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ejvs.2023.08.005","article-title":"Epidemiological trends and projections of incidence, prevalence, and disease related mortality associated with peripheral arterial disease: observations using nationwide Danish data","volume":"66","author":"S\u00f8gaard","year":"2023","journal-title":"Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg"},{"key":"10.1016\/j.jacc.2025.11.027_bib15","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.027_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1055\/s-2004-830408","article-title":"High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes","volume":"112","author":"Lange","year":"2004","journal-title":"Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc"},{"key":"10.1016\/j.jacc.2025.11.027_bib17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.027_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s12877-025-06228-6","article-title":"Trends of the burden, risk factors, and future projections of peripheral artery disease in the elderly","volume":"25","author":"Chen","year":"2025","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jacc.2025.11.027_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIR.0000000000001153","article-title":"Health disparities in peripheral artery disease: a scientific statement from the American Heart Association","volume":"148","author":"Allison","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.027_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/ATVBAHA.116.306258","article-title":"Arterial calcification in diabetes mellitus: preclinical models and translational implications","volume":"37","author":"Stabley","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2025.11.027_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/CIRCULATIONAHA.119.040672","article-title":"Microvascular disease, peripheral artery disease, and amputation","volume":"140","author":"Beckman","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.027_bib22","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/CIRCULATIONAHA.119.044775","article-title":"Dapagliflozin and cardiac, kidney, and limb outcomes in patients with and without peripheral artery disease in DECLARE-TIMI 58","volume":"142","author":"Bonaca","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.027_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2021.08.096","article-title":"Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial","volume":"75","author":"Govsyeyev","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.11.027_bib24","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1161\/CIR.0000000000001105","article-title":"Advancing peripheral artery disease quality of care and outcomes through patient-reported health status assessment: a scientific statement from the American Heart Association","volume":"146","author":"Smolderen","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.027_bib25","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.2337\/dc25-S010","article-title":"10. Cardiovascular disease and risk management: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.11.027_bib26","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.2337\/dc25-S005","article-title":"5. Facilitating positive health behaviors and well-being to improve health outcomes: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.11.027_bib27","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1161\/CIR.0000000000000967","article-title":"Reducing nontraumatic lower-extremity amputations by 20% by 2030: time to get to our feet: a policy statement from the American Heart Association","volume":"143","author":"Creager","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.027_bib28","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"387","author":"Farber","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib30","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","article-title":"Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association","volume":"126","author":"Aboyans","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.027_bib31","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2015.10.003","article-title":"The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine","volume":"63","author":"Hingorani","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.11.027_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor\u2019s choice: European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg"},{"key":"10.1016\/j.jacc.2025.11.027_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b79 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2025.11.027_bib34","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jacc.2008.09.063","article-title":"Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study)","volume":"53","author":"McDermott","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.027_bib35","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3390\/jcm13072141","article-title":"Peripheral arterial disease and the diabetic foot syndrome: neuropathy makes the difference! A narrative review","volume":"13","author":"R\u00fcmenapf","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.11.027_bib37","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib38","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.2337\/dc23-S012","article-title":"12. Retinopathy, neuropathy, and foot care: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.11.027_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/HCQ.0000000000000135","article-title":"Understanding the pain experience and treatment considerations along the spectrum of peripheral artery disease: a scientific statement from the American Heart Association","volume":"18","author":"Smolderen","year":"2025","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.11.027_bib40","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.amjcard.2019.03.022","article-title":"Incidence and cost of major adverse cardiovascular events and major adverse limb events in patients with chronic coronary artery disease or peripheral artery disease","volume":"123","author":"Berger","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.11.027_bib41","first-page":"797","article-title":"Canadian Cardiovascular Society clinical practice update on contemporary approaches to smoking cessation","volume":"41","author":"Mir","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2025.11.027_bib42","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","year":"1996","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jacc.2025.11.027_bib43","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial","volume":"71","author":"Anand","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.027_bib44","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib45","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib46","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib47","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib48","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa2501006","article-title":"Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes","volume":"392","author":"McGuire","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib49","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.117.032361","article-title":"Association of statin dose with amputation and survival in patients with peripheral artery disease","volume":"137","author":"Arya","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.027_bib50","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/eurheartj\/ehac709","article-title":"Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial","volume":"44","author":"Lee","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.027_bib51","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib52","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2010.07.031","article-title":"Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial","volume":"56","author":"Hennrikus","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.027_bib53","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0195-668X(03)00003-4","article-title":"Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study","volume":"24","author":"Tonstad","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.027_bib54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2008.962","article-title":"Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial","volume":"301","author":"McDermott","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.027_bib55","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cct.2013.09.011","article-title":"Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL Study","volume":"36","author":"Domanchuk","year":"2013","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jacc.2025.11.027_bib56","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.027_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"Belch","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.11.027_bib58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib59","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Investigators","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jama.2023.9696","article-title":"Bempedoic acid for primary prevention of cardiovascular events in statin-intolerant patients","volume":"330","author":"Nissen","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.027_bib61","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0140-6736(09)60698-X","article-title":"Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial","volume":"373","author":"Rajamani","year":"2009","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jacc.2025.11.027_bib62","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacc.2024.05.028","article-title":"Effect of pemafibrate on diabetic foot ulceration and gangrene: an exploratory analysis from PROMINENT","volume":"84","author":"Marinho","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.027_bib63","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib64","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib65","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-8587(24)00102-5","article-title":"Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis","volume":"12","author":"Usman","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2025.11.027_bib66","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2337\/dc24-1533","article-title":"Cardiovascular and kidney outcomes and mortality with long-acting injectable and oral glucagon-like peptide 1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of randomized trials","volume":"48","author":"Lee","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.11.027_bib67","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib68","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib69","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib70","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejvs.2014.06.041","article-title":"Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes","volume":"48","author":"Elgzyri","year":"2014","journal-title":"Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg"},{"key":"10.1016\/j.jacc.2025.11.027_bib71","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2337\/diacare.24.8.1433","article-title":"Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome","volume":"24","author":"Jude","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.11.027_bib72","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC Guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.027_bib73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11936-015-0434-6","article-title":"Glycemic control in coronary revascularization","volume":"18","author":"Ujueta","year":"2016","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.jacc.2025.11.027_bib74","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/1358863X14538330","article-title":"Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty","volume":"19","author":"Singh","year":"2014","journal-title":"Vasc Med Lond Engl"},{"key":"10.1016\/j.jacc.2025.11.027_bib75","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jvs.2021.09.040","article-title":"Predictors of outcome in diabetic patients undergoing infrapopliteal endovascular revascularization for chronic limb-threatening ischemia","volume":"75","author":"Yap","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.11.027_bib76","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.avsg.2021.12.002","article-title":"Preoperative HbA1c and outcomes following lower extremity vascular procedures","volume":"83","author":"Buelter","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jacc.2025.11.027_bib77","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.11.027_bib78","article-title":"Effectiveness of revascularisation for the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review","volume":"40","author":"Chuter","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jacc.2025.11.027_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2024.12.061","article-title":"Characteristics of multidisciplinary limb preservation teams and their impact on outcomes in the BEST-CLI trial","author":"Jones","year":"2025","journal-title":"J Vasc Surg"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725102829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725102829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:56:27Z","timestamp":1787669787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725102829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0735109725102829"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.11.027","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Peripheral Artery Disease in Adults With Diabetes: 2025 ACC Scientific Statement","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}